These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know? Kiltz U, Zochling J, Schmidt WE, Braun J. Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642 [Abstract] [Full Text] [Related]
24. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases. Ji KY, Hu FL. World J Gastroenterol; 2006 Jun 28; 12(24):3789-92. PubMed ID: 16804960 [Abstract] [Full Text] [Related]
25. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Gastroenterology; 2009 Nov 28; 137(5):1641-8.e1-2. PubMed ID: 19664631 [Abstract] [Full Text] [Related]
26. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, Axon A. Am J Gastroenterol; 2000 Jun 28; 95(6):1448-55. PubMed ID: 10894577 [Abstract] [Full Text] [Related]
30. Specifics of Helicobacter pylori infection/NSAID effects in the elderly. Davidovic M, Svorcan P, Milanovic P, Antovic A, Milosevic D. Rom J Gastroenterol; 2005 Sep 28; 14(3):253-8. PubMed ID: 16200236 [Abstract] [Full Text] [Related]
33. The effect of helicobacter pylori eradication on NSAID-induced gastrointestinal toxicity. Kanji S, Dumo P. Ann Pharmacother; 2001 Feb 28; 35(2):249-54. PubMed ID: 11215847 [Abstract] [Full Text] [Related]
34. Dyspepsia and Helicobacter pylori. Selgrad M, Kandulski A, Malfertheiner P. Dig Dis; 2008 Feb 28; 26(3):210-4. PubMed ID: 18463437 [Abstract] [Full Text] [Related]
35. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW. J Gastroenterol Hepatol; 2008 Dec 28; 23 Suppl 2():S278-85. PubMed ID: 19120912 [Abstract] [Full Text] [Related]
36. Helicobacter pylori in solid-organ transplant recipient. Ueda Y, Chiba T. Curr Opin Organ Transplant; 2008 Dec 28; 13(6):586-91. PubMed ID: 19060547 [Abstract] [Full Text] [Related]
37. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding. Mahachai V, Thomson AB, Vilaichone RK. J Med Assoc Thai; 2004 Sep 28; 87 Suppl 2():S295-9. PubMed ID: 16083206 [Abstract] [Full Text] [Related]
38. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S. Int J Infect Dis; 2009 Sep 28; 13(5):647-54. PubMed ID: 19233700 [Abstract] [Full Text] [Related]
39. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Liu Y, Akiyama J, Graham DY. Minerva Gastroenterol Dietol; 2006 Sep 28; 52(3):235-48. PubMed ID: 16971868 [Abstract] [Full Text] [Related]